Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regression

Journal of the American Academy of Dermatology

Volumn 24, Issue 5, 1991, Pages 731-734

  Buechner, Stanislaw A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SKIN CARCINOMA;

AGED; CARCINOMA, BASAL CELL; CELL COUNT; FEMALE; HLA-DR ANTIGENS; HUMAN; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2B; MALE; MIDDLE AGE; SKIN; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0025809190     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(91)70111-E     Document Type: Article

References (23)

1. The immunobiology of basal cell carcinoma: in situ monoclonal antibody study
2. The immunology of basal cell carcinoma
3. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumors
4. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma
5. 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate
6. Treatment of basal cell carcinoma with intralesional interferon
7. Treatment of large basal cell carcinomas with intralesional alpha-2a interferon
8. L'interferon alpha 2 dans les carcinomas basocellulaires: des espoirs à confirmer
9. Intralesional treatment of basal cell carcinoma with low-dose recombinant interferon gamma
10. On the varied biological effects of interferon
11. Interferon alpha. Current status and future promise
12. Interferon: status in treatment of skin disease
13. Interferons in dermatology
14. Antitumor actions of interferons: direct, indirect, and synergy with other treatment modalities
15. Treatment of neoplastic skin lesions with intralesional interferon
16. Direct cytolysis by partially-purified preparations of immune interferon
17. Enhancement by interferon on the specific cytotoxieity of sensitized lymphocytes
18. Interferon enhances antibody-dependent cellular cytotoxicity when suboptimal concentrations of antibody are used
19. Immunological effects of recombinant interferon alpha-2 in cancer patients
20. Recombinant interferon gamma increases HLA-DR synthesis and expression
21. Subpopulations of human natural killer cells defined by expression of the Leu7 (HNK-1) and Leu-11 (NK-15) antigens